Characterization of protein-based risk signature to predict prognosis and evaluate the tumor immune environment in breast cancer

CONCLUSION: This study established an effective prognostic proteomics signature with reliable predictive performance for survival, immune activity, and drug sensitivity. It might provide a novel perspective into the protein function in BC, and guide the individual treatment strategies for BC patients.PMID:36732487 | DOI:10.1007/s12282-023-01435-8
Source: Breast Cancer - Category: Cancer & Oncology Authors: Source Type: research